July 7th 2025
Coverage from “Tech Innovations in Community Oncology,” presented June 19, 2025, by Tennessee Oncology in Nashville, Tennessee. First of 4 parts.
CDC to Physicians: Watch for Severe Respiratory, Polio-Like Illness in Children
September 28th 2022The CDC this week noted what providers and parents have been seeing across the country: rising cases of a non-polio enterovirus causing severe respiratory illness and acute flaccid myelitis (AFM).
Read More
FAIR Health Releases Report on Substance Use Disorders, Overdoses Before, During Pandemic
September 27th 2022One of the key findings of the report is that 42 states saw an increase in the proportion of patients with opioid and opioid-like drug overdoses compared with the total number of patients using medical services by state.
Read More
Clostridioides difficile Infection Risk Greater Among Patients Requiring Maintenance Hemodialysis
September 27th 2022Patients requiring maintenance hemodialysis (MHD) had a 4-fold higher risk of Clostridioides difficile infection (CDI), with rates of CDI increasing over time regardless of MHD requirement.
Read More
AMA’s Dr James Madara to Discuss Precompetitive Positions and Innovation Needs at AAO
September 26th 2022During the Parker Heath Lecture at the American Academy of Ophthalmology (AAO) annual meeting, James Madara, MD, CEO of the American Medical Association (AMA), will discuss the 3 arcs of the AMA’s strategic framework and the innovation that needs to occur.
Watch
Skin Biomarkers Found to Predict Development of Pediatric Atopic Dermatitis
September 26th 2022Significant alterations were observed in lipid levels and other skin biomarkers for infants who developed atopic dermatitis (AD) vs controls, with phytosphingosine associated with the highest AD prediction accuracy.
Read More
Study Supports Comprehensive Genomic Profiling for Patients With Biliary Tract Cancer
September 24th 2022A small study suggests that comprehensive genomic profiling can help with clinical decision-making and predicting clinical outcomes in advanced biliary tract cancer, but further research is needed.
Read More
Examining Biologic-Related Adverse Events in CRS With Nasal Polyps
September 23rd 2022Headaches, injection site reactions, and pharyngitis were the most common adverse events associated with the biologic therapies dupilumab, omalizumab, mepolizumab, and reslizumab in the treatment of chronic rhinosinusitis (CRS) with nasal polyps.
Read More
A deal was reached to renew 5-year FDA user fee programs; children and adolescents with COVID-19 had a 60% increased risk of developing type 1 diabetes (T1D); states cannot penalize Department of Veterans Affairs (VA) employees for facilitating abortions permitted by federal law.
Read More
Childhood Trauma Not a Barrier to Successful Depression Treatment, Analysis Finds
September 22nd 2022Prior research has suggested that childhood trauma is linked with a poorer response to psychotherapy and prescription drug treatment for major depressive disorder, but a large meta-analysis suggested otherwise.
Read More
Multiple Pegfilgrastim Administration Options Allow for Patient-Centric Model of Care
September 20th 2022With 6 pegfilgrastim biosimilars approved, and multiple administration options, a patient-centric model of pegfilgrastim administration should be possible for patients with cancer who require prophylaxis of febrile neutropenia.
Read More
Nutrition Assistance No Guarantee Against Food Insecurity for Families Fighting Cancer
September 20th 2022A recent study showed that receiving Supplemental Nutrition Assistance Program benefits was not enough to address food insecurity among families whose children were fighting acute lymphoblastic leukemia.
Read More
A recent study found that 1 in 5 households were strapped with medical debt; hospitals and hospital systems in North Carolina proposed a way to expand Medicaid to hundreds of thousands of adults; the CDC reported that more adults sought mental health treatment in 2021 compared with 2019.
Read More
Optimizing Emergency Care Processes Improves Outcomes for Hospitalized Patients With HE
September 16th 2022Patients with hepatic encephalopathy (HE) often do not seek care until they are in critical condition, making an optimized emergency care process critical to reduce adverse prognosis and improve clinical symptoms.
Read More
Health experts warn that all should brace for a flu season that could be worse than the past 2 years; the CDC is opening applications to a vaccine equity program that will help those who may have limited access to the monkeypox vaccine; a new report found that health care services will be greatly affected by climate change.
Read More
Advocate Details Challenges Faced in Path to Diagnosis for Hidradenitis Suppurativa
September 16th 2022Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected by hidradenitis suppurativa (HS), discussed the misconceptions she faced from clinicians regarding her clinical symptoms of HS prior to diagnosis.
Watch
Researchers Evaluate Racism as a Factor in Underestimation of Atopic Disease
September 15th 2022Although allergic and atopic disease is well studied and researched overall, the researchers said there is a critical lack of knowledge about these conditions, including eosinophilic esophagitis, asthma, and atopic dermatitis, in diverse racial and ethnic groups.
Read More
David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, infectious disease clinical pharmacist at Temple University Hospital, provides an update on current preventive efforts to address the monkeypox public health emergency in the United States and what steps are needed to protect at-risk populations.
Read More
Dr Jason Ezra Hawkes on Diagnostic Challenges, Strategies in Atopic Dermatitis
September 10th 2022Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California Davis in Sacramento, spoke on diagnostic challenges for atopic dermatitis and tips for clinicians in screening for the condition.
Watch
Advocate Discusses Physical, Psychological Impact of Hidradenitis Suppurativa
September 9th 2022Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS), speaks on the quality of life burden she has experienced during her HS disease journey.
Watch